- Home
- CMS vs TEVA Comparison
CMS vs TEVA Comparison
Compare CMS & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMS
- TEVA
- Stock Information
- Founded
- CMS 1987
- TEVA 1901
- Country
- CMS United States
- TEVA Israel
- Employees
- CMS N/A
- TEVA N/A
- Industry
- CMS Power Generation
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- CMS Utilities
- TEVA Health Care
- Exchange
- CMS Nasdaq
- TEVA Nasdaq
- Market Cap
- CMS 22.3B
- TEVA 21.2B
- IPO Year
- CMS N/A
- TEVA N/A
- Fundamental
- Price
- CMS $74.34
- TEVA $24.97
- Analyst Decision
- CMS Buy
- TEVA Strong Buy
- Analyst Count
- CMS 12
- TEVA 7
- Target Price
- CMS $79.00
- TEVA $25.86
- AVG Volume (30 Days)
- CMS 2.8M
- TEVA 13.6M
- Earning Date
- CMS 10-30-2025
- TEVA 11-05-2025
- Dividend Yield
- CMS 2.91%
- TEVA N/A
- EPS Growth
- CMS N/A
- TEVA N/A
- EPS
- CMS 3.47
- TEVA 0.62
- Revenue
- CMS $8,295,000,000.00
- TEVA $16,776,000,000.00
- Revenue This Year
- CMS $8.81
- TEVA $4.11
- Revenue Next Year
- CMS $4.13
- TEVA $0.40
- P/E Ratio
- CMS $21.46
- TEVA $39.85
- Revenue Growth
- CMS 10.96
- TEVA 0.02
- 52 Week Low
- CMS $63.97
- TEVA $12.47
- 52 Week High
- CMS $76.45
- TEVA $26.38
- Technical
- Relative Strength Index (RSI)
- CMS 55.13
- TEVA 69.76
- Support Level
- CMS $73.15
- TEVA $23.61
- Resistance Level
- CMS $75.06
- TEVA $26.38
- Average True Range (ATR)
- CMS 1.21
- TEVA 0.86
- MACD
- CMS 0.06
- TEVA 0.23
- Stochastic Oscillator
- CMS 81.02
- TEVA 77.67
About CMS CMS Energy Corporation
CMS Energy is an energy holding company with three principal businesses. Its regulated utility, Consumers Energy, provides regulated natural gas service to 1.8 million customers and electric service to 1.9 million customers in Michigan. NorthStar Clean Energy, formerly CMS Enterprises, is engaged in wholesale power generation, including contracted renewable energy. CMS sold EnerBank in October 2021.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.